Correlation Between Tarsus Pharmaceuticals and Aptose Biosciences
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Aptose Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Aptose Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Aptose Biosciences, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Aptose Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Aptose Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Aptose Biosciences.
Diversification Opportunities for Tarsus Pharmaceuticals and Aptose Biosciences
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tarsus and Aptose is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Aptose Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptose Biosciences and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Aptose Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptose Biosciences has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Aptose Biosciences go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Aptose Biosciences
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.8 times more return on investment than Aptose Biosciences. However, Tarsus Pharmaceuticals is 1.25 times less risky than Aptose Biosciences. It trades about 0.09 of its potential returns per unit of risk. Aptose Biosciences is currently generating about -0.15 per unit of risk. If you would invest 1,609 in Tarsus Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 3,475 from holding Tarsus Pharmaceuticals or generate 215.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Aptose Biosciences
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Aptose Biosciences |
Tarsus Pharmaceuticals and Aptose Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Aptose Biosciences
The main advantage of trading using opposite Tarsus Pharmaceuticals and Aptose Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Aptose Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will offset losses from the drop in Aptose Biosciences' long position.| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
| Aptose Biosciences vs. CytomX Therapeutics | Aptose Biosciences vs. Instil Bio | Aptose Biosciences vs. Spero Therapeutics | Aptose Biosciences vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |